Pure Global AI
Switzerland flag

Switzerland medical device registration timeline

Source-linked clocks

Swiss Agency for Therapeutic Products (Swissmedic) review clocks and end-to-end planning ranges, using the 4-class (I, IIa, IIb, III) - EU MDR aligned classification system.

1 pathways1 of 1 clocks verifiedvalidity 5 years (aligned with CE certificate)MDSAP not acceptedreviewed 2026-08-29fedlex.admin.ch
Class / pathwayReview clockPlanning totalWith prior approvalProvenance
Class I(Self-declaration (no conformity assessment body))
MepV Art. 23 applies the EU MDR conformity assessment procedures, so a Class I device that is not sterile, has no measuring function and is not a reusable surgical instrument is self-declared with no body involved and no review clock
0 days3-5 months1-2 monthsVerified
Review clocks exclude applicant hold time · planning totals are estimates

Switzerland Medical Device Registration Process

Step-by-step Swissmedic registration process. Total estimated timeline: 3-5 months.

Step 1: Pre-Submission Preparation

1-3 months

Gather technical documentation, quality management system (QMS) records, and clinical data required by Swissmedic. Appoint a Swiss Authorized Representative (CH-REP).

Step 2: Application Submission

1-2 weeks

Submit complete registration dossier to Swissmedic including device description, risk analysis, and testing reports.

Step 3: Administrative Review

2-4 weeks

Swissmedic reviews application for completeness. May request additional documents or clarifications.

Step 4: Technical Evaluation

0 days

In-depth technical assessment of device safety and performance. Swissmedic may issue questions.

Step 5: Registration Approval

1-2 weeks

Upon successful review, Swissmedic issues Switzerland market authorization certificate.

Summary: The Switzerland medical device registration process through Swiss Agency for Therapeutic Products (Swissmedic) consists of 5 main steps: Pre-Submission Preparation → Application Submission → Administrative Review → Technical Evaluation → Registration Approval.
Expedited pathways
EU CE Mark RecognitionImmediate market access

Full recognition of EU CE marked devices until 2028

Eligibility: Valid EU MDR CE Mark, MDD CE Mark until expiry

Unilateral recognition of EU/EEA certificatesNo second conformity assessment

The device chapter of the EU-Switzerland MRA has not applied since 26 May 2021 and has not been restored; Switzerland instead recognises EU/EEA notified-body certificates one-way under MepV Art. 25(4), which is why a CH-REP and Swiss labelling are still required

Eligibility: Certificate from a body designated under EU law and established in an EU or EEA state, Procedures must meet Swiss requirements and the body must hold equivalent qualification

Prior approval recognition
EU CE Mark (MDR)Full recognition - immediate Swiss market accessImmediate
EU CE Mark (MDD)Recognized until certificate expiryImmediate
FDA 510(k)Documentation can support Swiss applicationIndirect
Key requirements
  • Swiss Authorized Representative (CH-REP) for foreign manufacturers
  • EU MDR technical documentation
  • Swiss specific labeling requirements
  • Swissmedic registration
  • Actor registration: manufacturers, CH-REPs and importers register in swissdamed within 3 months after first placing a product on the market (MedDO Art. 55; IvDO Art. 88)
  • Device registration: swissdamed UDI Devices module live since 18.08.2025; registration mandatory from 1 July 2026, with a transition period until 31 December 2026 for devices placed on the market before then
  • Clinical investigations (KlinV-Mep Art. 12): the ethics committee confirms receipt and flags formal deficiencies within 10 days, gives the sponsor 10 days to cure them, and decides within 40 days of confirming a formally correct dossier; the clock is suspended while additional information is outstanding
  • Multicentre investigations (KlinV-Mep Art. 13): the lead committee confirms receipt within 10 days (each deadline extendable by 5 days on request), the participating committees report their local assessment within 15 days, and the lead committee decides within 40 days
  • Swissmedic authorisation (KlinV-Mep Art. 19): receipt confirmed within 10 days, 10-day cure period extendable by 20 days, decision within 45 days of a formally correct dossier and only after the ethics committee has approved, extendable by up to 20 days for first-in-human use or a new manufacturing process; substantial amendments are decided within 38 days (+7)
Primary regulator sources

Reviewed 2026-08-29. End-to-end totals remain planning estimates.

Keep researching this market
View the Switzerland resource hub →
Compare timeline across all countries →
Source-linked review clocks verified against Swissmedic publications · full review 2026-08-29 · row IDs are stable — cite as registration-timeline:switzerland:class-i